BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 136 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $48,511 | -1.5% | 6,852 | -2.0% | 0.00% | – |
Q2 2023 | $49,238 | -11.7% | 6,994 | +4.7% | 0.00% | -100.0% |
Q1 2023 | $55,736 | -12.4% | 6,683 | +20.6% | 0.00% | 0.0% |
Q4 2022 | $63,634 | -9.1% | 5,543 | -0.7% | 0.00% | 0.0% |
Q3 2022 | $70,000 | +45.8% | 5,582 | +24.0% | 0.00% | 0.0% |
Q2 2022 | $48,000 | -34.2% | 4,501 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $73,000 | +17.7% | 4,501 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $62,000 | -4.6% | 4,501 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $65,000 | -8.5% | 4,501 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $71,000 | +54.3% | 4,501 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $46,000 | +35.3% | 4,501 | 0.0% | 0.00% | – |
Q4 2020 | $34,000 | +126.7% | 4,501 | 0.0% | 0.00% | – |
Q3 2020 | $15,000 | -28.6% | 4,501 | 0.0% | 0.00% | – |
Q2 2020 | $21,000 | +133.3% | 4,501 | 0.0% | 0.00% | – |
Q1 2020 | $9,000 | -43.8% | 4,501 | 0.0% | 0.00% | – |
Q4 2019 | $16,000 | +23.1% | 4,501 | 0.0% | 0.00% | – |
Q3 2019 | $13,000 | -23.5% | 4,501 | 0.0% | 0.00% | – |
Q2 2019 | $17,000 | -54.1% | 4,501 | +0.0% | 0.00% | -100.0% |
Q1 2019 | $37,000 | +2.8% | 4,500 | -0.0% | 0.00% | 0.0% |
Q4 2018 | $36,000 | +5.9% | 4,501 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $34,000 | +30.8% | 4,501 | +0.0% | 0.00% | – |
Q2 2018 | $26,000 | – | 4,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 7,637,700 | $77,675,000 | 7.44% |
Burrage Capital Management LLC | 864,916 | $8,796,000 | 7.13% |
ORACLE INVESTMENT MANAGEMENT INC | 2,367,670 | $24,079,000 | 3.61% |
HealthCor Management, L.P. | 4,886,440 | $49,695,000 | 1.76% |
Ghost Tree Capital, LLC | 500,000 | $5,085,000 | 1.20% |
Integral Health Asset Management, LLC | 400,000 | $4,068,000 | 1.16% |
Lisanti Capital Growth, LLC | 472,520 | $4,806,000 | 0.62% |
Parkman Healthcare Partners LLC | 244,680 | $2,488,000 | 0.58% |
Baker Brothers Advisors | 12,710,818 | $129,269,000 | 0.56% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,605,380 | $26,497,000 | 0.56% |